DIANA KAUFMAN: Open Payments
NPI 1720262652 · WATSEKA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
Products named: LEQVIO, BREZTRI, ZENPEP, AIRSUPRA, CAPLYTA, JARDIANCE, YUPELRI.
Industry payments across IL — which companies pay providers there.
